The InMode RF System including the InMode RF Hand piece (InMode MD Ltd.) is a computerized system generating RF energy with integral temperature and impedance feedback mechanism for procedures requiring electrocoagulation and hemostasis. The InMode RF System constantly monitors the temperature and impedance of the target treatment tissue, automatically adjusting energy delivery to maintain effective and safe tissue heating.

The InMode RF System consists of an AC/DC power supply unit, RF generator, controller and user interface including touch screen. The RF Hand piece is connected to the console via a cable and a foot switch activates the energy delivery to the hand piece. The hand piece is comprised of a disposable, single use; internal and external electrodes.

Following are the InMode RF System specifications: RF Max Output Power: 20 Watt RF Output Frequency: 1[MHz] ± 2% Dimension: 35cm W x 46cm D x 100cm H (14.2'' W x 18.2'' D x 40'' H) Weight: 15 Kg (33 lbs) Main Line Frequency (nominal): 50-60 Hz Input Voltage (nominal): 100-240 VAC

AI/ML Overview

The provided document is a 510(k) Premarket Notification from the FDA for the InMode RF System. It describes the device, its intended use, and demonstrates substantial equivalence to a predicate device (ThermiGen Symphony RF System, K130689).

However, this document does not contain information about acceptance criteria or a study proving that an AI/ML powered device meets acceptance criteria. Instead, it focuses on the performance of a radiofrequency medical device for electrocoagulation and hemostasis through bench testing and ex-vivo studies, comparing it to a predicate device.

Therefore, I cannot extract the requested information regarding acceptance criteria, study details for an AI/ML powered device, ground truth establishment, or multi-reader multi-case studies from this document. The document describes a traditional medical device clearance process, not one for an AI/ML based diagnostic or treatment device.

To answer your request, if this were an AI/ML powered device, the information would typically be found in detailed clinical study reports or regulatory submissions specifically addressing the performance of the AI algorithm.

Summary

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with three human profiles incorporated into its design. The eagle's wings are formed by the silhouettes of the human faces.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

February 19, 2016

InMode MD Ltd. % Ms. Ahava Stein A.Stein- Regulatory Affairs Consulting Ltd. 20 Hata'as Str., Suite 102 Kfar Saba, 4442520 Israel

Re: K151793

Trade/Device Name: InMode RF System Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: Class II Product Code: GEI Dated: January 17, 2016 Received: January 20, 2016

Dear Ms. Stein:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Jennifer R. Stevenson -S

For Binita S. Ashar, M.D., M.B.A., F.A.C.S. Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K151793

Device Name InMode RF System

Indications for Use (Describe)

The InMode RF System is indicated for use in dermatological and general surgical procedures for electro-coagulation and hemostasis.

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(K) SUMMARY INMODE RF SYSTEM

510(k) Number K151793

Applicant Name:

Company Name:	InMode MD Ltd.
Address:	Tabor Building, Shaar YokneamYokneam 20692Israel
	Tel: +972-4-9097470
	Fax: +972-4-9097471
	E-mail: amit@asteinrac.com; ahava@asteinrac.com

Contact Person:

Official Correspondent:	Ahava Stein
Company Name:	A. Stein – Regulatory Affairs Consulting
Ltd. Address:	20 Hata’as Str., Suite 102Kfar Saba 44425Israel
	Tel: +972-9-7670002Fax: +972-9-7668534E-mail: amit@asteinrac.com; ahava@asteinrac.com
Date Prepared:	June 25, 2015
Trade Name:	InMode RF System
Classification Name:	CFR Classification section 878.4400; (Product code GEI)
Classification:	Class II Medical Device

Predicate Device:

The InMode RF System is substantially equivalent to the following predicate device;

Manufacturer	Device	510(k) No.
ThermiGenInc.	ThermiGen Symphony RF	K130689

{4}------------------------------------------------

Device Description:

Intended Use/Indication for Use:

The InMode RF System is indicated for use in dermatological and general surgical procedures for electrocoagulation and hemostasis.

Performance Standards:

The InMode RF System has been tested and complies with the following voluntary recognized standards:

AAMI/ANSI 60601-1:2005/(R)2012 And A1:2012, C1:2009/(R)2012 And . A2:2010/(R)2012 (Consolidated Text) Medical Electrical Equipment - Part 1: General Requirements For Basic Safety And Essential Performance (IEC 60601-1:2005, Mod).
IEC 60601-1-2 Edition 3: 2007-03, Medical Electrical Equipment Part 1-2: ● General Requirements For Basic Safety And Essential Performance - Collateral Standard: Electromagnetic Compatibility - Requirements And Tests.
IEC 60601-2-2 Edition 5.0 2009-02, Medical Electrical Equipment Part 2-2: ● Particular Requirements For The Basic Safety And Essential Performance Of High Frequency Surgical Equipment And High Frequency Surgical Accessories.

{5}------------------------------------------------

Non-Clinical (Bench) Performance Data:

A set of bench tests were performed to measure the accuracy and consistency of the device cut-off temperature outputs of the InMode RF Hand piece and compare them to the specific design requirements. The results of the bench tests demonstrate that the InMode RF System complies with the device design requirements; the cut off temperature measurements were validated and maintained constant as predetermined by the system operator.

Bench Top Tissue Performance Data / Histology Data:

The thermal effects of the InMode RF System on the target tissue were evaluated in an comparative ex-vivo study. The study was conducted on three different porcine tissue models (muscle, liver & fat) and included a single RF treatment followed by histology analysis (for the fat tissue specimens an additional TTC staining method was assessed). The ex-vivo study results demonstrated similar tissue/histological effects for the subject and predicate devices.

Clinical Performance Data:

Not Applicable

Device	InMode RF System	ThermiGen Symphony RF
Characteristic	K151793	K130689
Product Code,	GEI,	GEI,
Class	Class II	Class II
IFU	The InMode RF System isindicated for use in dermatologicaland general surgical procedures forelectrocoagulation and hemostasis.	The Symphony RF System and theprobes that are used with it areindicated for use in dermatologicaland general surgical procedures forelectrocoagulation and hemostasis.
RF Power	Up to 20 W	Up to 20 W
Internal Cut-Off	50-70 oC	40-95 oC
Treatment Time	15-120 sec	15-120 sec
RF Frequency	1 MHz	0.46 MHz
Tissue impedance	50 -300 Ohm	50 -300 Ohm

Substantial Equivalence:

The indications for use and technological characteristics of the InMode RF System are substantially equivalent to the indications for use and technological characteristics of the ThermiGen Symphony RF System.

The design and components of the InMode RF System, including the console (with power supply, RF generator, controller and display panel) and the hand piece (with

{6}------------------------------------------------

cable, connector to console, handle and electrodes) are similar to the design and components found in the predicate ThermiGen Symphony RF System. The slight differences in the hand piece design do not raise new safety or effectiveness concerns. The performance specifications (including RF frequency, cut off temperature and pulse duration (treatment time)) of the InMode RF System were shown to be similar to those of the ThermiGen Symphony RF System. The safety features and compliance with safety standards in the InMode RF System are similar to the safety features and compliance with safety standards found in the predicate device. Patient contact materials are also similar. Any minor differences in the technological characteristics do not raise new safety or effectiveness concerns. Furthermore, the InMode RF System underwent performance testing, including software validation testing, electrical and mechanical safety testing according to IEC 60601-1 and IEC 60601-2-2, electromagnetic compatibility testing according to IEC 60601-1-2, bench testing and exvivo testing to evaluate the thermal effect of the device on the tissue. These performance tests demonstrated that the minor differences in the device design and specifications meet the system requirements and do not raise new safety or effectiveness concerns.

Consequently, it can be concluded that the InMode RF System is substantially equivalent to the predicate ThermiGen Symphony RF System, cleared under 510(k) K130689, and therefore, may be legally marketed in the USA.

Conclusions:

Based on the performance testing, ex-vivo testing and comparison to predicate device, the InMode RF System is substantially equivalent to the ThermiGen Symphony RF System predicate device.

Regulation Number and Section

§ 878.4400 Electrosurgical cutting and coagulation device and accessories.

(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.